These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 12542609)

  • 1. Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B infection.
    Dikici B; Bosnak M; Ucmak H; Dagli A; Ece A; Haspolat K
    J Gastroenterol Hepatol; 2003 Feb; 18(2):218-22. PubMed ID: 12542609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic vaccination in the immunotolerant phase of children with chronic hepatitis B infection.
    Dikici B; Kalayci AG; Ozgenc F; Bosnak M; Davutoglu M; Ece A; Ozkan T; Ozeke T; Yagci RV; Haspolat K
    Pediatr Infect Dis J; 2003 Apr; 22(4):345-9. PubMed ID: 12690275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of vitamin E in children with immunotolerant-phase chronic hepatitis B infection.
    Dikici B; Dagli A; Ucmak H; Bilici M; Ece A
    Pediatr Int; 2007 Oct; 49(5):603-7. PubMed ID: 17875084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lack of effect of therapeutic vaccination with a pre-S2/S HBV vaccine in the immune tolerant phase of chronic HBV infection.
    Yalcin K; Danis R; Degertekin H; Alp MN; Tekes S; Budak T
    J Clin Gastroenterol; 2003 Oct; 37(4):330-5. PubMed ID: 14506391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
    Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
    J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy for children with chronic hepatitis B virus infection.
    Dikici B; Bosnak M; Bosnak V; Dagli A; Ece A; Yagci RV; Haspolat K
    J Gastroenterol Hepatol; 2002 Oct; 17(10):1087-91. PubMed ID: 12201869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic vaccination in chronic hepatitis B.
    Senturk H; Tabak F; Akdogan M; Erdem L; Mert A; Ozaras R; Sander E; Ozbay G; Badur S
    J Gastroenterol Hepatol; 2002 Jan; 17(1):72-6. PubMed ID: 11895556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of switching from treatment with nucleos(t)ide analogs to pegylated interferon α-2a on virological and serological responses in chronic hepatitis B patients.
    He LT; Ye XG; Zhou XY
    World J Gastroenterol; 2016 Dec; 22(46):10210-10218. PubMed ID: 28028369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
    Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B.
    Li MH; Lu Y; Zhang L; Wang XY; Ran CP; Hao HX; Zhang D; Qu XJ; Shen G; Wu SL; Cao WH; Qi TL; Liu RY; Hu LP; Chang M; Hua WH; Liu SA; Wan G; Xie Y
    Chin Med J (Engl); 2018 Aug; 131(15):1813-1818. PubMed ID: 30058578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A randomized controlled study on factors influencing the curative effect of sequential combined interferon and lamivudine therapy in children with immune-tolerant phase chronic hepatitis B].
    Zhu SS; Dong Y; Zhang HF; Wang LM; Xu ZQ; Zhang M; Gan Y; Chen DW; Wang FC; Yan JG; Zhao P
    Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):604-609. PubMed ID: 31594077
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
    Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
    Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cytokines with hepatitis B virus and its antigen.
    Li MH; Chen QQ; Zhang L; Lu HH; Sun FF; Zeng Z; Lu Y; Yi W; Xie Y
    J Med Virol; 2020 Dec; 92(12):3426-3435. PubMed ID: 32662892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
    Demirören K; Kocamaz H; Doğan Y
    Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
    Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
    Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The follow-up of serum aminotransferase levels and investigation of hepatitis B virus load in inactive HBsAg carriers].
    Olut AI; Ozünlü H; Bozdağ H; Ozkalay N
    Mikrobiyol Bul; 2007 Jul; 41(3):429-33. PubMed ID: 17933254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study.
    Zhu S; Zhang H; Dong Y; Wang L; Xu Z; Liu W; Gan Y; Tang H; Chen D; Wang F; Zhao P
    J Hepatol; 2018 Jun; 68(6):1123-1128. PubMed ID: 29452204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
    Xiang Y; Chen P; Xia JR; Zhang LP
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.